All Stories

  1. Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review

    Article • PLoS ONE, April 2022, PLOS

    Dr Masayuki Hashiguchi

  2. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study

    Article • Modern Rheumatology, January 2018, Taylor & Francis

    Dr Masayuki Hashiguchi

  3. Effect of database profile variation on drug safety assessment: an analysis of spontaneous adverse event reports of Japanese cases

    Article • Drug Design Development and Therapy, June 2015, Dove Medical Press

    Dr Masayuki Hashiguchi

  4. Patients views and experiences in online reporting adverse drug reactions: findings of a national pilot study in Japan

    Article • Patient Preference and Adherence, January 2015, Taylor & Francis

    Dr Masayuki Hashiguchi, Kiyoshi Kubota